CClinicalTrials.gg
RecruitingNCT06622993P-SKILLSUpdated Jun 12, 2026

Effectiveness of the SKILLS Program in the Management of Psychiatric Disorders

An interventional study of Psychotherapy in Psychiatric Disorders, sponsored by University Hospital, Tours. Recruiting at 1 site in France. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-06-12.

Sponsored by University Hospital, Tours · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Started Nov 2024; still recruiting 1 year 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Epidemiological studies show that one person in eight suffers from at least one psychiatric disorder. Mental health is therefore a major public health issue, and care for these disorders must continue to be improved.

The management of mental disorders has long followed the traditional categorical approach of developing a treatment for a given disorder. However, researchers have recently pointed out the limits of this approach in the field of mental health. They highlight the large number of co-morbidities, the existence of aspecific disorders and the intra-diagnostic heterogeneity of patients. These factors have led them to develop a transdiagnostic approach, which focuses on the mechanisms common to the various disorders in order to treat them at the same time and thus reduce the cost of treatment.

02

Conditions studied

  • Psychiatric Disorders

Browse trials for

03

In context

Mental Disorders

2,107 studies on the registry are indexed under Mental Disorders; 416 are open to participants now.

This study's planned enrollment of 60 is below the median of 94 across 1,574 interventional studies indexed under Mental Disorders.

Browse Mental Disorders studies →

Lead sponsor

University Hospital, Tours is the lead sponsor of 304 studies on the registry; 78 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Male or female ≥ 18 years of age
  • Have at least one diagnosis of a psychiatric disorder
  • Be able to carry out psychotherapy sessions
  • Have been on stable psychiatric medication for 30 days
  • Written informed consent obtained from the participant
  • Be affiliated to a social security scheme or equivalent

Exclusion criteria

Exclusion Criteria:

  • Cognitive deficits marked by a score above the 10th percentile for one or more tests in the assessment history.
  • Persons deprived of liberty by judicial or administrative decision; Persons under legal protection: guardianship or curatorship
  • Presence of a severe depressive episode
  • Be engaged in psychotherapeutic work elsewhere
  • Presence of a state of excessive deficit, making psychotherapy impossible
  • Presence of psychic decompensation (e.g. delusions) making psychotherapy impossible
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Programm SKILLS

    Other: Psychotherapy

  • No intervention
    Waiting list

Interventions

  • OtherPsychotherapy

    The experimental group will receive the SKILLS program, i.e. 10 group psychotherapy sessions.

06

What researchers measure

Primary outcomes

  1. Evolution in Symptom Checklist Scale (SCL 90) scores between randomization and Month 3

    Time frame: At the randomisation and Month 3

Secondary outcomes

  1. Evolution of Transdiagnostic Skills Scale (T2S) score

    Time frame: At randomisation, Month 3 and Month 6

  2. Evolution of Symptomatic Transdiagnostic Test (S2T) score

    Time frame: At randomisation, Month 3 and Month 6

  3. Evolution of Hosptital Anxiety Depression Scalre (HADS) score

    Time frame: At randomisation, Month 3 and Month 6

  4. Evolution of Satisfaction with Life Scale (SWLS) score

    Time frame: At randomisation, Month 3 and Month 6

  5. Cumulative quantity of psychotropic treatment taken by patients (in mg)

    Time frame: At randomisation, Month 3 and Month 6

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06622993
Lead sponsor
University Hospital, Tours
Responsible party
Sponsor
First posted
Oct 2, 2024
Start date
Nov 14, 2024
Primary completion
Nov 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Jun 12, 2026

Study contacts

VANCAPPEL
Contact
alexis.vancappel@univ-tours.fr
+33247477111

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion